Fundamental Analysis
85 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +246.5% | +137.4% | 3 / 3 | +27.7% | +1.82 pp | +11.70 pp | +13.7% | 0.00 | 7.43 | 38,8 | +27,7% | 7,0 | +265,2% | 7.43 | 13.19 | −43,7% |
| Pts | 12 | 12 | 12 | 12 | 8 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 18.000 (close price on 2026-10-16)EPS (TTM): 2.423
Financial charts
1.Revenue & growth
VND bn38,8Q2/26
1.Revenue & growth
VND bn38,8Q2/26
2.Profit & growth
VND bn6,92Q2/26
3.Profit mix (Penman)
VND bn37,9Q2/26
4.Margins & cost structure
%17.0%Q2/26
5.Returns & cash cycle
% · days10.9%Q2/26
6.Earnings quality & cash
VND bn10,8Q2/26
7.Asset structure
VND bn287Q2/26
8.Funding & debt health
VND bn · times287Q2/26
9.Revenue backlog
VND bn0,55Q2/26
10.Valuation
times · %7,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %500Q2/26
Adjusted EPS growth, latest quarter
246%
Average adjusted EPS growth, 3 quarters
141%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
4.9%
Source: vnstockData through Q2/26